Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001968582-23-000772
Filing Date
2023-12-13
Accepted
2023-12-13 17:18:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3101
  Complete submission text file 0001968582-23-000772.txt   4718
Mailing Address C/O PROTAGONIST THERAPEUTICS, INC. 521 COTTONWOOD DRIVE, SUITE 100 MILPITAS CA 95035
Business Address
PATEL DINESH V PH D (Reporting) CIK: 0001120477 (see all company filings)

State of Incorp.: DE
Type: 144

Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Subject) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37852 | Film No.: 231484930
SIC: 2834 Pharmaceutical Preparations